Stock Scorecard
Stock Summary for Harrow Inc (HROW) - $47.90 as of 1/16/2026 9:57:57 PM EST
Total Score
6 out of 30
Safety Score
40 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HROW
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HROW
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HROW
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HROW
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HROW (40 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HROW
Financial Details for HROW
Company Overview |
|
|---|---|
| Ticker | HROW |
| Company Name | Harrow Inc |
| Country | USA |
| Description | Harrow Health, Inc. is a prominent healthcare company headquartered in San Diego, California, focused on developing and commercializing cutting-edge ophthalmic products. Leveraging its proprietary formulations and sophisticated drug delivery technologies, Harrow Health enhances patient outcomes for a variety of ocular conditions and surgical procedures. With a robust pipeline of FDA-approved therapies, the company is well-positioned to capitalize on the growing demand for advanced eye care solutions in the expanding ophthalmology market. Committed to innovation and excellence in patient-centered care, Harrow Health aspires to be a transformative leader in global ophthalmic health. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 3/25/2026 |
Stock Price History |
|
| Last Day Price | 47.90 |
| Price 4 Years Ago | 14.76 |
| Last Day Price Updated | 1/16/2026 9:57:57 PM EST |
| Last Day Volume | 393,764 |
| Average Daily Volume | 589,987 |
| 52-Week High | 54.85 |
| 52-Week Low | 20.85 |
| Last Price to 52 Week Low | 129.74% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 101.18 |
| Sector PE | 54.65 |
| 5-Year Average PE | -14.98 |
| Free Cash Flow Ratio | 23.83 |
| Industry Free Cash Flow Ratio | 11.46 |
| Sector Free Cash Flow Ratio | 28.78 |
| Current Ratio Most Recent Quarter | 2.72 |
| Total Cash Per Share | 2.01 |
| Book Value Per Share Most Recent Quarter | 1.27 |
| Price to Book Ratio | 37.99 |
| Industry Price to Book Ratio | 15.26 |
| Sector Price to Book Ratio | 43.34 |
| Price to Sales Ratio Twelve Trailing Months | 7.13 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.86 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.82 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 37,037,500 |
| Market Capitalization | 1,774,096,250 |
| Institutional Ownership | 58.40% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -64.00% |
| Annual Earnings Growth | 28.39% |
| Reported EPS 12 Trailing Months | -0.13 |
| Reported EPS Past Year | 0.08 |
| Reported EPS Prior Year | -0.21 |
| Net Income Twelve Trailing Months | -4,988,000 |
| Net Income Past Year | -17,481,000 |
| Net Income Prior Year | -24,411,000 |
| Quarterly Revenue Growth YOY | 45.40% |
| 5-Year Revenue Growth | 31.29% |
| Operating Margin Twelve Trailing Months | 20.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 74,290,000 |
| Total Cash Past Year | 47,247,000 |
| Total Cash Prior Year | 74,085,000 |
| Net Cash Position Most Recent Quarter | -168,584,000 |
| Net Cash Position Past Year | -172,292,000 |
| Long Term Debt Past Year | 219,539,000 |
| Long Term Debt Prior Year | 183,172,000 |
| Total Debt Most Recent Quarter | 242,874,000 |
| Equity to Debt Ratio Past Year | 0.24 |
| Equity to Debt Ratio Most Recent Quarter | 0.16 |
| Total Stockholder Equity Past Year | 69,652,000 |
| Total Stockholder Equity Prior Year | 70,357,000 |
| Total Stockholder Equity Most Recent Quarter | 47,016,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -20,474,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.55 |
| Free Cash Flow Past Year | -60,876,000 |
| Free Cash Flow Prior Year | -148,713,000 |
Options |
|
| Put/Call Ratio | 0.38 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.02 |
| RSI | 0.00 |
| 50-Day SMA | 34.79 |
| 150-Day SMA | 26.65 |
| 200-Day SMA | 22.51 |
System |
|
| Modified | 1/15/2026 10:21:07 PM EST |